Request a copy of the file
Enter the following information to request a copy for the following item: Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
Requesting the following file: VandenNesteEAndréM-Haematologica2018.pdf